Multiple sclerosis often strikes between the ages of 20 and 40, when people are entering the workforce and raising families.
Turning against the self
Multiple sclerosis is an incurable illness in which the body’s own immune system destroys tissues in the central nervous system. T cells and B cells are thought to remove a protective coating called myelin that wraps around nerve fibres in the brain, spinal column and optic nerve. Exposed fibres are degraded, producing symptoms that vary depending on where the damage occurs.
A difficult diagnosis
Symptoms differ from person to person, making diagnosis difficult. Common symptoms include vision problems, weakness, instability and loss of bladder control. The proportion of people with some of the most common symptoms are shown below.
Types of multiple sclerosis
Relapsing–remitting multiple sclerosis (RRMS) produces attacks followed by periods of remission that can last months or years. It usually gets worse with time. In primary progressive multiple sclerosis (PPMS), symptoms worsen steadily without remission.
What causes multiple sclerosis?
The cause is unknown, but it is thought to involve an interplay of genetics and the environment. Genetic susceptibility drives the risk, but the contribution of any specific gene seems to be modest.
Global incidence
Multiple sclerosis is most common in northern latitudes, reflecting the likely association with reduced exposure to sunlight and vitamin D deficiency.
Disease-modifying therapies
Several drugs have been approved for RRMS, but none for PPMS. Drugs need to be given as soon as possible to slow the pace of neurological damage.
Sources
Multiple Sclerosis International Federation Atlas of MS 2013 (MSIF, 2013) MS Brain Health National Multiple Sclerosis Society gilenyahcp.com/Novartis Pharmaceuticals
Related links
Related links
Related links in Nature Research
Multiple sclerosis: Dimethyl fumarate is coming of age
Multiple sclerosis: Fingolimod failure in progressive MS INFORMS future trials
Multiple sclerosis in 2015: Managing the complexity of multiple sclerosis
Decade in review—multiple sclerosis: New drugs and personalized medicine for multiple sclerosis
FDA reversal sends mixed message to multiple sclerosis community
Related external links
Rights and permissions
About this article
Cite this article
Schmidt, C. Biology: A degenerative affliction. Nature 540, S2–S3 (2016). https://doi.org/10.1038/540S2a
Published:
Issue Date:
DOI: https://doi.org/10.1038/540S2a